Product Branding, e-Marketing May Be Underutilized
Strengthened pharmaceutical branding and increased utilization of online marketing tools can have a significant impact on the revenue and market value of pharmaceutical firms, according to a presentation by Bill Trombetta, professor of pharmaceutical strategy and marketing at The Erivan K. Haub School of Business at St. Joseph's University.
Pharmaceutical Marketing in Texas: Look Out for State Privacy Laws!
This article provides an update on medical privacy legislation in Texas and its effect on pharma marketing in that state. Included is an analysis of bill SB 330 and SB 1136, which were signed into law in the Spring of 2003, These laws will have an impact on the ability of pharmaceutical companies to market their products in Texas.
Proactive eMarketing Plan Should Be Implemented Through Strategic Plan, Augmentation of Sales Force
Pharmaceutical companies can effectively implement e-marketing programs through strategic planning and by simply augmenting their traditional sales force, suggested Devin Paullin, vice president of operations at Physicians Interactive.
Ethical Online Practices Build Consumer Trust
Although pharmaceutical firms claim they are not required to comply with regulations enacted under the Health Insurance Portability and Accountability Act of 1996, using HIPAA as a model for online policy may help drug companies improve their public images, build trust with consumers and, ultimately, sell more products.
Effective Marketing to Consumers: Drug Marketers Need More Than Demographic Data
Pharmaceutical firms should use not only demographic data but technological and health dimension data as well when developing direct-to-consumer marketing tools, suggested Michael J. Barrett, senior analyst at the marketing research firm Forrester Research, Inc.
Product Branding, eMarketing May Be Underutilized
Strengthened pharmaceutical branding and increased utilization of online marketing tools can have a significant impact on the revenue and market value of pharmaceutical firms, according to a presentation by Bill Trombetta, professor of pharmaceutical strategy and marketing at The Erivan K. Haub School of Business at St. Joseph's University.
Product Branding, e-Marketing May Be Underutilized
Strengthened pharmaceutical branding and increased utilization of online marketing tools can have a significant impact on the revenue and market value of pharmaceutical firms, according to a presentation by Bill Trombetta, professor of pharmaceutical strategy and marketing at The Erivan K. Haub School of Business at St. Joseph's University.
PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
A power shift from marketing to medical affairs may be the result of the new PhRMA Code on Interactions with Healthcare Professionals as well as the final Compliance Program Guidance for Pharmaceutical Manufacturers issued on April 28, 2003, by the HHS Office of Inspector General (OIG).
PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
A power shift from marketing to medical affairs may be the result of the new PhRMA Code on Interactions with Healthcare Professionals as well as the final Compliance Program Guidance for Pharmaceutical Manufacturers issued on April 28, 2003, by the HHS Office of Inspector General (OIG).
Pharma Marketing Network Survey Results
The ongoing Pharma Marketing Network Improvement Survey continues to yield interesting information about members and their preferences.
